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Background: Aggressive metastatic breast cancer cells seemingly evade surgical resection and current therapies,
leading to colonization in distant organs and tissues and poor patient prognosis. Therefore, high-throughput in vitro
tools allowing rapid, accurate, and novel anti-metastatic drug screening are grossly overdue. Conversely, aligned
nanofiber constitutes a prominent component of the late-stage breast tumor margin extracellular matrix. This
parallel suggests that the use of a synthetic ECM in the form of a nanoscale model could provide a convenient
means of testing the migration potentials of cancer cells to achieve a long-term goal of providing clinicians an
in vitro platform technology to test the efficacy of novel experimental anti-metastatic compounds.
Methods: Electrospinning produces highly aligned, cell-adhesive nanofiber matrices by applying a strong electric
field to a polymer-containing solution. The resulting fibrous microstructure and morphology closely resembles
in vivo tumor microenvironments suggesting their use in analysis of migratory potentials of metastatic cancer cells.
Additionally, a novel interface with a gel-based delivery system creates CXCL12 chemotactic gradients to enhance
CXCR4-expressing cell migration.
Results: Cellular dispersions of MCF-10A normal mammary epithelial cells or human breast cancer cells (MCF-7 and
MDA-MB-231) seeded on randomly-oriented nanofiber exhibited no significant differences in total or net distance
traveled as a result of the underlying topography. Cells traveled ~2-5 fold greater distances on aligned fiber. Highly-
sensitive MDA-MB-231 cells displayed an 82% increase in net distance traversed in the presence of a CXCL12
gradient. In contrast, MCF-7 cells exhibited only 31% increase and MCF-10A cells showed no statistical difference
versus control or vehicle conditions. MCF-10A cells displayed little sensitivity to CXCL12 gradients, while MCF-7 cells
displayed early sensitivity when CXCL12 concentrations were higher. MDA-MB-231 cells displayed low relative
expression levels of CXCR4, but high sensitivity resulting in 55-fold increase at late time points due to CXCL12
gradient dissipation.
Conclusions: This model could create clinical impact as an in vitro diagnostic tool for rapid assessment of tumor
needle biopsies to confirm metastatic tumors, their invasiveness, and allow high-throughput drug screening
providing rapid development of personalized therapies.
Keywords: Topography, Cell motility, Chemotaxis, MDA-MB-231, MCF-10A, MCF-7* Correspondence: lannutti.1@osu.edu
5Department of Materials Science and Engineering, Ohio State University, 143
Fontana Labs, 116 W 19th Ave, Columbus, OH 43210-1179, USA
Full list of author information is available at the end of the article
© 2014 Nelson et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Nelson et al. BMC Cancer 2014, 14:825 Page 2 of 16
http://www.biomedcentral.com/1471-2407/14/825Background
One in eight women in the United States will develop
malignant breast cancer in her lifetime [1]. Current ther-
apies for triple negative breast cancer (TNBC) remain sur-
gery, chemotherapy, and/or radiotherapy [2-5]. However,
highly-metastatic tumor cells can invade local tissues and
intravasate blood vessels to establish distant metastases in
spite of primary resection or treatment, resulting in a 20%
mortality rate after 5 years [1,6,7]. Novel, experimental
anti-metastatic drugs and compounds that specifically
target metastatic cells are grossly overdue. Effective,
personalized anti-metastatic diagnostic and therapeutic
approaches have been impeded due to a lack of in vitro
models that adequately recapitulate cell invasion/migra-
tion mechanisms [4,8-10] to allow for rapid develop-
ment of anti-metastatic drugs [11-16].
Each local and distant metastasis are multi-step proces-
ses that require cancer cells to leave the primary tumor by
migrating through the dense extracellular matrix (ECM)
within the tumor, at the tumor-stroma interface, and
within the stroma allowing intravasation and downstream
colonization [6,17,18]. In breast cancer, the microenviron-
ment changes significantly from onset to late stage cancer
[9,19-22]. One of the most influential parameters that
drives tumor cell migration and subsequent invasion of
surrounding ECM is topography [23-26]. Aggressive can-
cer cells follow “the path of least resistance” to invade
ECM and encounter distal blood or lymphatic vessels for
intravasation [27-29]. Tumor-associated collagen signa-
tures, specifically TACS-3, as described by Conklin et al.,
is characterized by radially-organized, highly-aligned colla-
gen fibers/bundles located at the tumor-stroma interface
potentially providing a topography that enables rapid stro-
mal invasion [25,30]. Clinical observation of these aligned
collagen bundles oriented perpendicular to the tumor
boundary using histological evaluation of patient biop-
sies correlates to poor prognosis and reduced treatment
efficacy [25,31].
In vitro models designed to assess tumor cell meta-
static potential vary considerably and typically possess
both advantages and disadvantages. Commonly used
models (scratch or Boyden chamber assays) lack quanti-
tative assessment of true cell migration or invasion,
allow only limited imaging opportunities or are charac-
terized by the absence of microstructural features com-
monly found in the tumor microenvironment [32-35].
More specifically, scratch and Boyden chamber assays
are both intimately connected to cellular proliferation.
The metric for analyzing migration in each assay re-
quires quantification of the area of cell occupancy or
the total number of cells present. Furthermore, in either
system cells are adhered to flat, 2D substrates meaning
that migration takes place on surfaces lacking topogra-
phical cues. In vitro assays that more closely recapitulatein vivo microenvironments can better assess qualitative
and quantitative biological phenomenon of cancer cell
migration and invasion, chemotherapeutic effectiveness,
novel anti-metastatic drug development, and attempt to
provide patients with personalized treatment options.
Johnson et al. previously demonstrated that aligned elec-
trospun nanofibers closely resemble the morphology and
microstructure of white matter tracts in the brain known
to facilitate rapid dispersion of glioma brain cancer cells
[33,36]. Electrospun nanofibers can exhibit fiber diameters
having the same magnitude as hyaluronan fibers and provide
sufficient adhesion allowing U251 glioma cells to migrate
efficiently on these aligned “cell highways” [33] while little
migration was observed on random nanofiber [33,36,37].
In addition to morphology of electrospun nanofiber, the
pseudo-3D environment provides a fibrous microstructure
similar to that of in vivo tissues [38-41].
In this report, aligned and randomly-oriented nanofi-
ber arrays are integrated with a gel-based chemotaxis
system to assess the migratory potential of MCF-10A
mammary epithelial cells as well as MCF-7 and MDA-
MB-231 breast cancer cell lines. As hypothesized, the
more highly metastatic MDA-MB-231 cells [42] migra-
ted further and at greater velocities relative to the less
metastatic MCF-7 cells on aligned nanofiber as a result
of topographic and chemotactic guidance. In contrast,
migration on randomly-oriented nanofiber resulted in
little difference in total or net distance traveled between
cell lines. As a more direct corollary to clinical samples,
xenograft MDA-MB-231 tumors from SCID mice were
explanted and cultured on aligned nanofiber arrays,
where quantitative assessment of tumor cell migration
displayed significant increases in total and net migration
in the presence of a CXCL12 gradient. Aligned nanofi-
ber topography and CXCL12 chemotactic gradients sig-
nificantly enhanced cellular migration. Such nanofiber
assays could provide useful in evaluating the metastatic
potential of tumor biopsies.
Methods
Electrospinning
Polycaprolactone (PCL, 80,000 MW, Sigma-Aldrich) na-
nofiber scaffolds were manufactured as before via elec-
trospinning [36]. Briefly, a 5 w/w% solution of PCL in
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP, >99% purity,
Oakwood Chemicals Inc.) was prepared by continuous
stirring at room temperature. This solution was placed in
a 60 ml syringe with a 20 gauge blunt tip needle and elec-
trospun using a high voltage DC power supply (Glassman
High Voltage, Inc.) set to +16 kV, a 20 cm tip-to-substrate
distance [43] and a 5 ml/hour flow rate. Nanofiber was de-
posited onto an aluminum collector rotating at 15 m/s,
covered with tissue culture treated polystyrene (TCPS)
until a 100 μm thick layer was achieved. PCL nanofiber
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insure removal of residual solvent [44], and then plasma
treated (Harrick Plasma) to promote cellular attachment
[36], and subsequently affixed to 24-well cell culture plates
for cellular experiments. Finally, using gamma-irradiation
(Sterigenics) the plates were sterilized. Prior to inoculat-
ing cells onto PCL nanofiber plates, 1 mL of PBS (Sigma-
Aldrich) was added to each of the wells and aspirated after
30 min.
Electrospun PCL nanofiber microstructure and mor-
phology was analyzed using a Sirion FEG scanning elec-
tron microscope (SEM) at an accelerating voltage of
5 kV. Aligned and randomly deposited PCL nanofiber
scaffolds were affixed to aluminum mounts with double-
sided carbon tape (SPI Supplies Inc.) and then gold-
sputter coated. Images of nanofiber general orientation,
morphology, and microstructure were taken and ImageJ
used to determine degree of alignment and fiber diam-
eter from 5 different randomly taken images.
Gel-based chemotaxis
100 ng recombinant human (rh)CXCL12 (CXCL12/SDF-
1α, R&D Systems Inc.) was mixed into 200 μL agarose
and pipetted onto the wall of a 24-well plate culture well
while the plate was tilted at a 45° angle to prevent the
agarose from spreading across the bottom of the well be-
fore fully solidifying. The resulting gel body consists of a
small ‘bead’ of approximately 3 mm in length at the edge
of each well.
To test the protein release rate, BSA-conjugated fluores-
cein isothiocyanate (BSA-FITC, Sigma-Aldrich) was used
as a model. Using the method previously stated above,
1 mg of BSA-FITC was mixed with agarose and added to
24-well plate culture wells. Release of the BSA-FITC was
conducted by adding 1 mL of PBS to each well, and after
each time point a 20 uL aliquot of the release solution
(PBS containing released BSA-FITC) was removed and
added to 180 uL of pure-PBS in a 96-well plate. After
24 hours, all aliquots taken and contained in the 96-
well plate were examined using a fluorescent 96-well
plate spectrometer (Spectra Max 190 Absorbance UV–
VIS plate reader) at an excitation wavelength of 485 nm
and the fluorescent intensity measured at the emission
wavelength of 535 nm. Using a serial dilution in PBS,
a calibration curve was then used to convert the data
to mg/mL concentration and plotted relative to time
(Additional file 1).
Cellular methods and reagents
MCF-10A human normal mammary epithelial cells,
MCF-7 (ATCC® HTB-22™) and MDA-MB-231 (ATCC®
HTB-26™) human breast cancer cells were grown in an
incubator under 5% CO2 using Dulbecco's Modified
Eagle Medium: Nutrient Mixture F-12 (DMEM/F-12)media, supplemented with 10% fetal bovine serum (FBS)
and 1% penicillin/streptomycin. In addition, explanted
GFP-labeled MDA-MB-231 breast tumors from SCID
mice (Jackson Laboratories, strain NOD.CB17-Prkdc <
scid>/J, The Ohio State University Institutional Animal
Care and Use Committee approved our study utilis-
ing breast tumours from SCID mice (protocol number
2011A00000077)) were used. All cells used in experiments
were from the same passage (no greater than 5) and were
stained just prior to migration using 0.4 μL of CellTracker™
Green CMFDA (5-chloromethylfluorescein diacetate) live
cell dye (Invitrogen, Cat. # C2925, USA). Cellular motion
was detected by exciting the dye using an exposure time of
50 msec at a laser excitation wavelength of 485 nm and
detecting emission at 535 nm on an Olympus IX81 con-
focal time-lapse microscope. Cellular viability inoculated
on tissue cultured polystyrene (TCPS) versus electrospun
PCL nanofiber (aligned or randomly oriented) was as-
sessed using an XTT cell viability assay (Roche, Cat.
11465015001) as per the manufacturer’s protocol.
qRT-PCR for CXCR4 mRNA expression
The expression of CXCR4 mRNA (receptor for CXCL12)
was analyzed over a 24 hour period for all three cell
lines to determine if exposure to its CXCL12 ligand over
time transcriptionally regulates CXCR4 gene expression.
1.5×105 cells were inoculated in 24-well plates in triplicate
with or without 100 ng of rhCXCL12 (R&D Systems, Inc;
350-NS-010). After 0, 2, 8, or 24 hours of culture, 1 mL of
TRIzol reagent (Invitrogen) was added to lyse the cells
and all lysate was collected and frozen in −20 C until fur-
ther processing.
Purified RNA was obtained using the RNeasy Minikit
(QIAGEN) as per the manufacturer’s protocol. The RNA
pellets was allowed to dry for 15 min before 20 μL of
nuclease-free water was added to each of the samples in
preparation for spectroscopy examination (Nanodrop,
Thermo Scientific). cDNA was synthesized using the Su-
perscript First Strand Synthesis System (Invitrogen) and
used for real-time polymerase chain reaction (PCR) using
SYBR Green PCR Master Mix (Applied Biosciences). The
following primers: hCXCR4 forward: 5’-AGCATGACG
GACAAGTACAGG-3’ and hCXCR4 reverse: 5’-GATGA
AGTCGGGAATAGTCAGC-3’ were designed using Pri-
mer Express, Version 3.0 software (ABI Prism; PerkinElmer
Life and Analytical Sciences) and synthesized by Invitro-
gen. Data were analyzed according to the comparative




MDA-MB-231 cells were plated to confluence in 6-well
culture plates containing Dulbecco’s Modified Eagles
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mycin/amphotericin B (PSA) for scratch assay observa-
tion. Using a pipette tip, three horizontal scratches were
made across the diameter of the well. In addition, on
the bottom/back of each well, a line perpendicular to
the scratches was drawn with a permanent marker. The
monolayer was washed one time with PBS to remove
any floating cells generated by the scratching process
and fresh media applied. Using an inverted microscope,
photos at the intersection of each cell scratch and the
line on the bottom of the plate were captured immedi-
ately (six images per well) and used as a reference point
for the 16 h time point to determine percentage scratch
coverage.
Boyden/transwell assay
A 24-well plate of 8.0 μm pore-size diameter polycar-
bonate (PC) membrane transwell inserts (Corning, Cat. #
3422, USA) were pretreated with complete DMEM/F12
culture medium prior to cell inoculation. Inserts were
rinsed with 1% FBS DMEM/F12 cell culture medium 2×
and 600 μL of depleted DMEM/F12 medium added to the
lower compartment of each transwell insert. 50,000 cells
suspended in 100 μL of DMEM/F12 medium (supple-
mented with 1% FBS) or 1.5 mg/mL col I matrix gel were
added to the upper compartment of the transwell and
allowed to adhere for 8 hours. After allowing the cells to
adhere and become appropriately (protocol for “Transwell
Permeable Supports,” Corning Inc.) serum starved, the
transwells were moved to new wells containing DMEM/
F12 medium (supplemented with 1% FBS) with or without
100 ng/mL CXCL12 chemokine. After 24 hours, trans-
wells of each condition assessed in triplicate were re-
moved, the upper compartment side of the PC membrane
wiped clean using a cotton swab and washed with fresh
DMEM/F12 culture medium and the backside or lower
compartment side of the membrane imaged. Four images
from each membrane were taken from representative lo-
cations, and the number of cells present was counted and
the average number of cells per experimental condition
was reported.
Electrospun nanofiber assay
In addition, 1.05×104 cells per cm2 were inoculated on
aligned or randomly oriented electrospun PCL nanofiber
in a 24-well cell culture plate to evaluate the migratory
potential of three different cell lines. 100 μL cell suspen-
sions were added to each well in triplicate, with or with-
out gel, and with or without gel loaded with rhCXCL12.
Cells were allowed to adhere for 2 hour before 1 mL of
culture medium was added to each of the wells, denot-
ing the starting time at which time-lapse confocal mi-
croscopy began. Three imaging locations with in each of
the wells were recorded and subsequently imaged every30 min for 24 hours. After 24 hours, all of the images at
each representative location were chronologically con-
verted into a time-lapse video from which cell migratory
analysis was conducted. Using the MTrackJ cell motion
plugin for ImageJ, 25 randomly-selected cells from each
video were tracked and the total distance of migration,
net distance of migration, and velocity was recorded.
The total distance of migration was determined as the
sum of each individual cell displacement that occurred.
Conversely, net distance of migration was calculated as
the net sum of the individual cell vectors with respect to
a reference or with respect to an initial position at time
zero (when no gradient was present). Migration velocity
was recorded as an average over the full 24 hour time
period, and as the average velocity with respect to each
time point throughout the 24-hour time-lapse period.
Multi-photon imaging
100 micron sections of Met-1 murine breast tumor, cre-
ated from cells orthotopically implanted into the number
4 mammary gland of wild type C57Bl/6 female mouse
sample, were obtained using a vibratome. Image stacks
were captured using an Olympus FV100MPE micro-
scope equipped with a 25X XLPlan water immersion
objective lens (1.05 N.A>) and a Mai Tai DeepSee Ti:
Sapphire tunable laser (Spectra-Physics, Newport Corp.).
Second Harmonic Generation (SHG) detection of collagen
was performed at a wavelength of 950 nm while backscat-
tered SHG signals were detected at 855 nm. An image
series was captured using an optical zoom of 2×. Both
image stacks are presented as a two dimensional image
projections.
Statistical analysis
All quantitative results are displayed as the average value ±
the standard deviation. To determine statistical significance
Minitab 16 statistical software was employed. Using a 95%
confidence interval an ANOVA was conducted for each
variable independently and as interacting factors and
p-values less than 0.05 resulted in a null-hypothesis re-
jection. Further analysis was conducted using a Tukey’s
comparison test to more thoroughly determine statistical
significance between levels of different variables and their
potential interactions using a 95% confidence interval.
Results
Microscopy analysis
Commonly used tissue culture polystyrene (TCPS) differs
greatly in microstructure and morphology as compared
to electrospun PCL nanofiber. Figure 1(a-c) depicts scan-
ning electron microscopy (SEM) images of TCPS (a), ran-
domly oriented (b), and aligned PCL nanofiber (c). TCPS
displays a smooth, flat microstructure lacking micro-
scale topographical features. In contrast, electrospun
Figure 1 Confocal microscopy images displaying breast cancer cell morphology. (a) reveals the featureless morphology of standard, high
modulus flat tissue culture polystyrene. (b) The morphology of random nanofibers as-spun. (c) The topography of relatively well-aligned
nanofiber. Confocal images of MDA-MB-231 cells cultured on: (d) flat tissue culture polystyrene, random nanofiber (e) and (f) aligned nanofiber.
The cells on polystyrene display no net alignment. On random nanofiber they display indecisive alignment, pointing in directions dictated by cell
attachment to specific nanofibers. On aligned fiber the cells align in the direction of the underlying fiber and begin migrating.
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and micro-scale (inter-fiber pores) topographical features
present within the tumor extracellular matrix (Figure 2).
Figure 1(b) illustrates how randomly oriented fiber micro-
structure greatly differs from that of aligned nanofiber (a).
Table 1 displays average alignment and fiber diameter for
the random and aligned PCL nanofiber. No statistical dif-
ference was found between fiber diameters in Figure 1(b)
random vs. Figure 1(c) aligned. On average, random fibers
were 697 ± 58 nm in diameter. Aligned PCL nanofibers
displayed slightly larger fiber diameters of 795 ± 125 nm.
Significant differences (p < .005) were observed comparing
fiber alignment in Figure 1(b) to that of Figure 1(c). 87.7%Figure 2 Multiphoton microscopy images of collagen fibers from an e
collagen fibers near the central core (a) of a MDA-MB-231 xenograft breast
tumor-stroma boundary.of the nanofibers seen in Figure 1(c) are aligned in the same
direction, while only 5.6% were considered within 5 degrees
of each other in the random fiber image (Figure 1(b)).
Confocal images of MDA-MB-231 breast cancer cells
were captured to illustrate differences in cell morphology
observed on different substrates. Cells grown on TCPS
(Figure 1(d)) display a rounded, spherical shape and exhibit
both flat lamellipodia and filopodia. Figure 1(e) displays
MDA-MB-231 cells grown onto randomly-oriented nanofi-
ber where they exhibit a mixture of spherical and highly
elongated cells. These cells appear to adhere to single
PCL fibers (unhindered by neighboring fibers) to result in
elongated, spindle-shaped cell morphologies. At the samexplanted xenograft MDA-MB-231 tumor. Images show dense
tumor, and (b) radially aligned collagen fibers invading the
Table 1 Quantitative information on fiber alignment
(based on 25 measurements) and average diameter
(based on 25 measurements)
Alignment Fiber diameter (nm)
Aligned PCL 87.7 ± 5%*** 795.4 ± 125
Random PCL 5.6 ± 45% 697.9 ± 58
***Denotes statistical significance, p = .0002.
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play a more spherical morphology. In Figure 1(f) the high
degree of alignment suggests that few such intersections
exist, therefore the majority of these cells (>95%) display
this elongated shape in the direction of fiber alignment.
Figure 2(a, b) demonstrates multi-photon, second har-
monic generated (SHG) images of collagen I fibers located
within explanted Met-1 mouse breast tumors resected
from orthotopically-implanted tumor-bearing mice. Near
the core of the tumor (Figure 2(a)), collagen fibers (yellow)
are dense and display a variety of orientations. It appears
that these fibers are more randomly oriented within the
tumor stroma. At the tumor-stroma boundary, fibers are
organized into aligned microstructures and radially ori-
ented away from the center of the tumor. Arrows indicate
a marked number of radially aligned collagen fibers ori-
ented perpendicularly to the tumor-stroma boundary
(Figure 2(b)). These collagen fibers are highly aligned and
well organized to provide preferential, enhanced migration
of metastatic tumor cells [25,31].Figure 3 Scratch assay data detailing the migration of cells out from
(a) confluent MDA-MB-231 cells were scratched presenting at 100 μm wide
original area remains.Cellular migration
Figure 3(a-c) illustrates a traditional scratch/wound heal-
ing assay evaluating MDA-MB-231 cellular migration on
TCPS. MDA-MB-231 cells were cultured to confluence
in serum-containing media on TCPS at the start of the
experiment (Figure 3(a)). After 16 hours, only 48% of
the scratch area remains (Figure 3(b)). A total distance
of 100 μm spans the exposed area, limiting the net
quantitative information obtainable.
Boyden or transwell chambers are widely used to
evaluate cell migration in response to a chemotactic
gradient. MCF10A, MCF7 and MDA-MB-231 cells were
inoculated on these porous, 2D substrates with and
without the presence of a collagen matrix as an invasive
barrier to assess their migration through 8 μm pores in
response to the applied CXCL12 gradient. Figure 4
displays the cell counts for each cell line after 24 h.
MCF10A cells displayed migrated cell counts statisti-
cally identical to that of MCF7 cells. However, MDA-
MB-231 cells displayed 50 and 32% greater cell counts
for the control and collagen I conditions, respectively.
In the presence of CXCL12 the MCF10A cells displayed
a 13% increase, the MCF7 cells a 28% increase, and
MDA-MB-231 cells a 29% increase in the number of
cells present on the backside of the membrane. When a
collagen I barrier + CXCL12 gradient are present, the
MCF10A and MCF7 cells display no statistical differ-
ence in counts while MDA-MB-231 cells display a 29%a confluent monolayer onto a featureless ‘scratch’. At time = 0 h
gap with 100% area remaining. (b,c) After 16 hours only 48% of the
Figure 4 Boyden chamber data showing the number of cells present on the lower compartment of a transwell membrane after 24 h.
MDA-MB-231 cells displayed the greatest number of cells present. On average MDA-MB-231 exhibited a 29% increase in cell count in the
presence of the CXCL12 gradient. The collagen I gel barrier proved to discriminate against the MCF10A and MCF7 cells migratory ability more so
than the MDA-MB-231 cells. Symbols denote statistically significant differences between experimental conditions, p <0.05. (#) for MDA-MB-231,
(*) for MCF7, and (^) for MCF10A.
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of a CXCL12 gradient.
For each cell line, Figure 5 displays total distance trav-
eled versus random or aligned PCL nanofiber with or
without the presence of the CXCL12 chemotactic gradi-
ent. In all instances, cells seeded on aligned nanofiber
display significantly greater travel than the same cells in-
oculated on randomly oriented nanofiber (Additional
files 2 and 3). In addition, no significant differences in
the total distance traveled were observed on random
fiber with or without the presence of CXCL12, for eachFigure 5 Total distance traveled of MDA-MB-231, MCF-7 and MCF-10A
(‘control’), in the presence of a gel (‘vehicle’) and versus exposure to
approximately 136% farther on aligned versus random fiber but were not s
MCF-7 cells was very similarly governed by aligned versus random fiber top
an average 1.5-fold increase. The total distance traveled by MDA-MB-231 ce
MCF-10A cells (and was similarly unaffected by the presence of the gradien
line. Total MDA-MB-231 travel in the presence of the chemical gradient wa
(time-lapse video footage of cell migration on random and aligned nanofib
significant differences between experimental conditions, p <0.05.of the cell lines. MCF-10A cells inoculated on aligned
fiber displayed no significant difference in total migra-
tion when comparing either control vs. vehicle or in the
presence of a CXCL12 gradient. However, they migrated
136% further compared to MCF-10A cells inoculated on
random fiber. Likewise, MCF-7 cells displayed a 98% and
MDA-MB-231 cells a 145% increase in total distance trav-
eled on aligned fiber vs. randomly oriented PCL nanofiber.
MCF-7 cells inoculated on aligned fiber in the presence of
CXCL12 displayed a 61% increase in total distance trav-
eled compared to either control or vehicle. MDA-MB-231cells on aligned and random fibers in the absence of a gel
a gel-based CXCL-12 gradient (‘CXCL12’). MCF-10A cells traveled
ensitive to the presence of the gradient. The total distance traveled by
ographies however the presence of the CXCL-12 gradient resulted in
lls on random fiber was very similar to that of the MCF-7 and
t) but total travel on aligned fiber was at 87% greater that either MCF
s not statistically different than in the absence of the gradient.
er substrates, Additional files 2 and 3). (#) Denotes statistically
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113% increase in total distance traveled over MCF-7 and
MCF-10A cell lines, respectively.
Figure 6 displays the results for net distance traveled
for each of the cell lines, with respect to direction of a
CXCL12 gradient (Additional file 4). As seen previously
in Figure 5, no significant difference in net distance trav-
eled was observed between the different cell lines when
inoculated on randomly oriented PCL nanofiber regard-
less of the presence of a CXCL12 gradient. Significant
(p < .05) 1.5-fold increases in net distance traveled were
observed when comparing MCF-7 cells migrating in the
presence of a CXCL12 gradient vs. MCF-10A or MCF-7
control or vehicle conditions. While MDA-MB-231 cells
did not show any significant statistical difference in total
distance traveled on aligned fiber in Figure 5, significant
differences were observed when examining net distance
traveled (Figure 6). MDA-MB-231 cells migrated 43%
further on aligned fiber in the presence of a CXCL12
gradient compared to control or vehicle conditions, a
392% increase over cells seeded on randomly aligned
nanofiber. In addition, MDA-MB-231 cells migrated 82%
further in the presence of a CXCL12 gradient compared
to MCF-7 or MCF-10A cells on aligned PCL nanofiber.
Table 2 displays the initial (average velocity between 0
to 8 h) and final (average velocity between 16 to 24 h)
velocities for each of the cell lines (MCF-10A, MCF-7,
and MDA-MB-231) inoculated on random or aligned
nanofiber and with or without the presence of CXCL12
gradients. No significant differences in the Vi vs. Vf for
all cell lines with respect to the control or vehicle testing
conditions were observed. However, MDA-MB-231 cellsFigure 6 Net distance traveled of MDA-MB-231, MCF-7 and MCF-10A
(‘control’), in the presence of a gel (‘vehicle’) and versus exposure to
similar to those of Figure 5 except that net MDA-MB-231 travel is 45% grea
(time-lapse video footage of cell migration on aligned nanofiber with appl
statistically significant differences between experimental conditions, p <0.0display a statistically significant decrease in velocity from
Vi to Vf of 40.2% resulting in a −1.21 μm/h
2 deceleration
over 24 hours. These data suggest that aligned nanofiber
provides a superior substrate for cellular migration com-
pared to randomly oriented nanofiber, yielding both the
greatest total and net distance traveled. MCF-10A nor-
mal cells migrate effectively but do not respond to the
applied CXCL12 gradient. With increasing metastatic
potential, significant increases in total and net migration
were observed in the presence of CXCL12.
To compare tumor cells grown in vitro to explanted
xenograft GFP-expressing MDA-MB-231 breast tumor
cells, tumors were resected from female SCID mice and
applied onto aligned nanofiber to evaluate the migra-
tion potential of biopsied cells on this novel platform,
ex vivo. Figure 7(a, b) illustrates MDA-MB-231 cells
at the start of the experiment (a), and at later times (b) as
they escape the tumor explant, adhering to aligned PCL
nanofibers and effectively migrating in the principle direc-
tion of alignment. The spread of tumor cells is clearly evi-
dent in Figure 7(b) compared to Figure 7(a) as is the
directionality of spread along the alignment, following the
CXCL12 gradient (Additional file 5). Initially, tumor cells
displayed rounded, spherical morphologies prior to attach-
ing to the aligned nanofiber substrate, and a significant
shift in cell morphology was observed after cell attach-
ment on aligned nanofiber was observed with the tumor
cells then displaying elongated, spindle-like morphologies.
We observed a 25% increase in total distance and a 23%
increase in net distance traveled for MDA-MB-231 tumor
cells migrating on aligned nanofiber substrates in the pres-
ence of a CXCL12 gradient (Table 3).cells on aligned and random fibers in the absence of a gel
a gel-based CXCL-12 gradient (‘CXCL12’). Observed trends are very
ter and statistically different from that of the control or the vehicle.
ied CXCL12 chemotactic gradient, Additional file 4). (#) Denotes
5.
Table 2 Initial and final velocities of all three cell lines on









[ [t avg = 1-8 h]
Final velocity
(um/h)
[ [t avg =16-24 h]
Control MCF-10A Random 2.05 ± 1 1.81 ± 1
Aligned 10.85 ± 8 10.02 ± 4
MCF-7 Random 3.01 ± 3 4.1 ± 4
Aligned 11.06 ± 8.4 10.86 ± 5.4
MDA-MB-231 Random 10.85 ± 8 6.1 ± 10
Aligned 31.6 ± 14 29.8 ± 7
Vehicle MCF-10A Random 2.95 ± .85 1.61 ± 1
Aligned 11.25 ± 3 10.1 ± 3
MCF-7 Random 2.71 ± 2 3.92 ± 2
Aligned 10.36 ± 4 10.56 ± 2
MDA-MB-231 Random 10.03 ± 6 8.1 ± 2
Aligned 28.4 ± 17 25.8 ± 10
CXCL12 MCF-10A Random 3.1 ± 5 2.0 ± 2
Aligned 11.31 ± 4 12.1 ± 5
MCF-7 Random 7.1 ± 5 6.0 ± 3
Aligned 15.26 ± 13 15.82 ± 5
MDA-MB-231 Random 11.2 ± 6.1 5.1 ± 6
Aligned 32.3 ± 13 19.3 ± 9***
***Denotes statistical significance, p = .00001.
No significant difference was seen for any of the cell-lines early vs. late for the
control or vehicle experimental conditions. MDA-MB-231 cells displayed a
significant drop in velocity in presence of a CXCL12 gradient from early to late
time points resulting in a −1.21 um/h2 deceleration, likely due to the
dissipation of the gradient at later time points and inherent sensitivity of the
CXCR4 receptor.
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Figure 8 indicates no significant difference in cell viabil-
ity between MCF-10A, MCF-7, or MDA-MB-231 cells
grown on fiber versus TCPS.
To understand if differences in CXCL12-mediated
cell migration were due to relative expression of CXCR4Figure 7 Tumor cell migration from explanted MDA-MB-231 tumors a
migration on aligned nanofiber substrates, Additional file 5).mRNA (the receptor for CXCL12), we performed qRT-
PCR for CXCR4 gene expression. MCF-10A are nor-
mal mammary epithelial cells while MCF-7 (estrogen
and progesterone receptor positive, HER2 negative)
and MDA-MB-231 (estrogen, progesterone, and HER2
receptor negative) cells represent two different breast
cancer cell lines with increasing metastatic potential
[42]. We hypothesized that sensitivity to CXCL12 gra-
dients may differ between these cells and possibly
modulate migratory potential. We cultured these cell
lines in the presence of an agarose-bead containing
rhCXCL12 over 24 hours. We found significant differ-
ences in basal CXCR4 mRNA expression (t = 0 hours)
between the MCF-10A and MCF-7 cells (~33-fold in-
crease) compared to MDA-MB-231 cells (p < 0.0001))
(Figure 9). Interestingly, our data indicates that CXCL12
exposure transcriptionally augments CXCR4 in both
MCF-10A and MCF-7 cells as we observed an 11-fold
and 7.5-fold increase, respectively, in CXCR4 mRNA
expression after 2 hours. Expression patterns between
these two cell lines were similar as CXCR4 mRNA ex-
pression was reduced at 8 hours (4-fold decrease for
MCF10-A and 5-fold decrease for MCF-7) then again
subsequently increased at 24 hours as CXCL12 was
depleted (5-fold increase for MCF10-A and 15-fold
decrease for MCF-7) suggesting that each MCF-10A
and MCF-7 cells respond to initial exposure of CXCL12
by up-regulating CXCR4 transcription. After 8 hours
exposure to CXCL12, CXCR4 transcription is sup-
pressed. At 24 hours, when CXCL12 availability is
diminished, CXCR4 transcription is once again aug-
mented. To the contrary, the MDA-MB-231 cell
CXCR4 mRNA expression profile is not augmented
with initial or prolonged exposure (up to 8 hours) of
CXCL12 as we observed no significant difference be-
tween time 0, 2, and 8 hours. But, at 24 hours, CXCR4
mRNA levels increase 55-fold relative to basal levels
(p < 0.0002).fter (a) 1 and (b) 24 hours. (time-lapse video footage of tumor cell
Table 3 Distance traveled and velocity for cells emerging







Control 200 ± 10 85 ± 7 9.25 ± 3
CXCL12 250 ± 8** 105 ± 9*** 11 ± 1
**Denotes statistical significance, p = 0.001.
***Denotes statistical significant, p = 0.0001.
The gradient has no statistical effect on either velocity or net distance
although the total distance traveled shows a statistically significant 25%
increase. However, the velocities of cells emerging from the explanted tumors
are approximately 1/3 those of seeded cells while the distances traveled are
approximately ½ those of seeded cells.
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Biomimicry and cellular morphology
Extracellular matrices are heterogeneous, 3D composites
consisting of proteins arranged in fibrous morphologies.
Normal breast tissue architecture is highly organized
into macroscopic hollow cylindrical ducts comprised of
epithelial cells organized into layered sheets anchored to
a basal lamina through integrin interactions that form
acinus structures [44-46]. Normal breast tissue will re-
pair, reorganize, and remodel the epithelial lining from a
polarized bilayer into a proliferative, motile, multilayered
epithelium that facilitates ductal growth, maturation,
and repair [9]. This normal ductal morphogenesis does
not include the local dissemination of individual cells
not unlike breast cancer tumorigenesis [22]. Early to late
stage progression of breast cancer results in an increase
in cellular proliferation within the duct, increased number
of acinus, and late stage metastasis increasing desmoplasia
and resulting in loss of cell-cell and basal lamina adhesion
leading to stromal invasion [44,47]. Normal mammary
duct extracellular matrix (ECM) is less dense, formed
mostly from collagen type I fibrils oriented randomly to
support epithelium and ductal architecture [45]. The epi-
thelial basal lamina, in contrast, is mostly composed ofFigure 8 Viability of MCF-10A, MCF-7, and MDA-MB-231 cells on TCPS vcollagen type IV that forms thick fiber bundles oriented
into aligned sheets parallel to the duct-stromal boundary
[44].
In this context we have evaluated the relative ability of
electrospun nanofibers to recapitulate such structures to
provide information on migration versus more trad-
itional assays (Figure 10). The normal mammary consists
of ducts displaying randomly oriented ECM fibers also
observed in the random electrospun fibers (10b1), and as
the tumor progresses it generates highly aligned ECM
(as well as Figure 2) guiding attachment and migration/
invasion in vivo also observed in the aligned electrospun
fibers (10b2). Pre-malignant tumorgenesis is accompan-
ied by increased collagen deposition causing crowding
and disruption of the basement membranes which then
gives way to morphogenesis in which the desmoplasia of
transformed cells break through the basement mem-
brane along more radially aligned ECM fibrils that aid in
local invasion and migration. In contrast, both the stan-
dard scratch/wound healing assay (10c) and the Boyden
Chamber (10d) consist of confluent cells adhered to 2D,
flat surfaces that provide no topographical guidance.
While Boyden/transwell chamber assays allow easy insti-
tution of chemotactic gradients they prevent quantitative
observation of cell motility while providing quantitative
assessments of cellular ability to migrate through an
8 μm pore. Finally, Table 4 succinctly summarizes the
relative characteristics of each assay.
SEM images of TCPS (Figure 1(a)) show the mor-
phology of the substrate used for scratch assays. These
substrates lack the nanofibrillar architecture of normal
breast tissue (Figure 2) and cannot present topographical
or orientation challenges characteristic of ECM sur-
rounding a breast tumor [25,31]. The random orien-
tation of the electrospun PCL nanofibers (Figure 1(b))
better resembles the microstructure of pre-cancerous or
early stage breast ECM architecture [25,31,45] wheres. electrospun substrates; no statistical differences were detectable.
Figure 9 CXCR-4 cell surface receptor expression for breast cancer cells is displayed. (LEFT) Relative CXCR-4 expression to GAPDH versus
time for the MCF-10A, MCF-7 and MDA-MB-231 cells on electrospun PCL. CXCR-4 expression for MCF-10A and MCF-7 cells prior to CXCL12
exposure display significantly greater expression compared to MDA-MB-231 cells. This trend is conserved over time post-exposure to CXCL12.
(RIGHT) Fold-change in CXCR-4 expression with respect to fresh cells for MCF-10A and MCF-7 cells remains relatively constant over 24-hr time
period. The MDA-MB-231 cells, however, show a dramatic reduction in CXCR-4 expression followed by a 55-fold rebound after 24 h. (#) Denotes
statistically significant differences between experimental conditions, p <0.05.
Figure 10 Schemas of breast architecture at various tumor progression stages as well as common scratch or Boyden chamber in vitro
assays are displayed with the developed nanofiber based migration platform. Schematic illustrations of (a) normal mammary (a1),
pre-malignant mammary tumor (a2), and mammary tumor collagen fiber distribution and organization (a3), topographically mimicked by “random”
and “aligned” electrospun fiber (Figure 1(b), (c)). (b) Cell organization on electrospun fiber in a random organization (b1) resembling normal,
pre-malignant mammary duct ECM; cell organization on aligned electrospun nanofibers (b2) recapitulates the local microenvironment at the
tumor-stroma boundary of radially oriented highly aligned ECM fibrils and enhances the migratory potential of tumor cells. (c) The standard
“scratch/wound healing” assay depicting the random movement of cells across the ‘scratch’ driven by population pressure. (d) The Boyden/
transwell chamber migration assay in which cells migrate through 8 μm pores and appear on the other side of the membrane.
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Table 4 Critical comparisons of specific input and output characteristics for three different in vitro migration assays
Scratch/wound healing Boyden/transwell Aligned nanofiber
Sample Pool for Analysis Confluent monolayer Individual cells Individual cells/tumor tissue
Biomimetic (−) (−) (+)
Proliferation Dependent (+) (+) (−)
Chemotaxis (−) (+) (+)
Output % of scratch remaining Cell count Net and total distance (μm)
Velocity Assessment % area closed w/r/t time NA Velocity (μm/h)
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causing the underlying microenvironment to become
extremely dense resulting in an increase in elastic mo-
dulus [21,48,49]. As the ECM evolves and mutations
to ductal cells arise during early-mid stage metastasis,
biochemical signaling drives local stromal cells to un-
dergo differentiation that defines them as tumor-aiding
or tumor-associated cells. The most common such cells
are tumor-associated macrophages (TAMS) and fibro-
blasts [25,30,50-53]. TAMs and fibroblasts allow tumor
cell migration through basal lamina by increased col-
lagen I deposition, matrix degradation, and collagen fi-
ber reorientation [54]. TACS-3 has been shown to be a
major clinical diagnostic signature of poor survival [25]
and is associated with the realignment of the tumor-
stromal boundary’s ECM and highly-aligned collagen fi-
bers oriented radially or perpendicular to the tumor
boundary, enhancing invasion [25,31]. Newly formed,
radially-aligned matrix acts as metastatic “cell highways”
directing the migration/invasion of advanced-stage breast
cancer cells providing potential for local and distant me-
tastasis. Electrospun PCL nanofibers in Figure 1(c) closely
resemble radially-aligned collagen fibril microenviron-
ments characteristics of late-stage metastatic breast cancer
[25,31] (Figure 2). The evolution of the mammary duct’s
microstructure from healthy tissue to aggressive late-stage
breast cancer defines, initiates, and drives the early stages
of metastasis making the physical microenvironment of a
breast tumor an obligate feature of in vitro cell migration
analysis.
Confocal images of MDA-MB-231 cells on 2D sub-
strates (TCPS) vs. 3D substrates (electrospun nanofiber)
provide insight to how cell morphology adapts to differ-
ent topographies. MDA-MB-231, MCF-10A and MCF-7
cells were imaged and cellular morphology analyzed
(Additional files 6, 7, 8, 9, 10, and 11). Each cell type dis-
played spherical shapes on TCPS accompanied by a mix-
ture of flat or spindle-like projections. MDA-MB-231
cells displayed more spindle-like morphologies on nano-
fiber where the elongations followed the underlying top-
ography. The observation of spindle-like cell-shapes as a
result of significant elongation directly correlates to in-
creased motility and migration potential [33,55]. Under-
lying topography has been shown to regulate FAK andRho/Rac genes that play an essential role in motility
allowing for step-wise migration and changes in cell po-
larity in response to chemotactic gradients [28,48,56].
Aligned fiber and phenotype
In each case, aligned PCL nanofiber allowed for greater
migration distance compared to randomly-oriented na-
nofiber. This outcome recapitulates results in tissue bi-
opsies from late stage breast cancer patients in which
significant rearrangement of fibers oriented radially from
the tumor provides direct pathways for invasion into the
stroma. This observation has been termed ‘contact medi-
ated guidance’, and is clinically associated with TACS-3
[28]. By closely observing the time-lapse video of cells
on randomly-oriented nanofiber it is evident that cells
still possess the ability to migrate but as the topography
consists of many crossing or intersecting fibers this pre-
vents significant progress across the matrix. Figure 1
shows MDA-MB-231 cells migrating to close the gap in
a scratch assay conducted on TCPS. Time-lapse micros-
copy indicates that the cells close the gap in a random,
wave-like fashion driven by swelling cellular populations
as a result of high rates of proliferation. In contrast,
in vivo cell metastasis is thought to be a highly-directed,
orchestrated process that depends on timing, coopera-
tion with the environment, and biochemical signaling
[4,57]. Flat, featureless TCPS has little resemblance to
in vivo tissue ECM. In addition, Boyden/transwell assay
analysis in Figure 4 depicted that the cells show very little
difference in migratory capabilities without a gel present,
and more pronounced effects when a gel is present. The
highly porous membrane that defines the transwell assay
is not a suitable barrier to assess the chemotactic migra-
tion of these cells alone. Also, the lack of quantitative out-
puts from this type of assay and lack of migration
observation make analysis less clear. Electrospun na-
nofiber provides a unique platform to quantitatively and
qualitatively assess cellular migration, and in these experi-
ments include diffusion-based chemotaxis. Time-lapse mi-
croscopy tracked individual cell movements allowing for
quantitative analysis of distance traveled, net distance trav-
eled, and velocity.
In this study, cells having different levels of metastatic
potential were evaluated to assess the ability of nanofiber
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CXCL12 chemotactic gradients. MCF-10A cells are nor-
mal, healthy mammary epithelial cells; while MCF-7 and
MDA-MB-231 cells are breast cancer cells. MDA-MB-
231 cells are late-stage, metastatic breast cancer cells
known to have a high metastatic potential that we hy-
pothesized would correlate to increased migration po-
tential and sensitivity to chemotactic gradients. While this
paper does not directly assess epithelial-to-mesenchymal
transition (EMT) hallmarks, such as loss of E-cadherin, in-
tegrin signaling, and increased Rho-GTPase signaling
driving cell motility and polarity for directed migration, it
is thought that many of these factors might play a role in
the observed results [47,58-60]. However, as a result of
passaging and growth on featureless TCPS or glass, many of
the in vivo characteristics of these cell lines are lost. That
said, an as-expected increase in migration was observed
from MCF-10A to MDA-MB-231 cells, showing that with
increased metastatic potential at least some of the cellular
machinery associated with enhanced motility is preserved.
Interestingly, this trend is not observed on random fiber,
suggesting that matrix orientation and topography is as
important as cellular phenotype or mutation accumulation
in driving metastatic potential. The presence of CXCL12
gradients caused significant increases in total and net dis-
tance traveled for MCF-7 and MDA-MB-231 cells. How-
ever, this response was not observed on random fiber as a
result of the random nanofiber topography hindering mi-
gration. An 82% increase in net distance traveled was ob-
served for MDA-MB-231 cells, resulting in nearly 320 μm
of migration. While metastasis is highly dependent on
tumor vascularization and size, the presence of aligned
nanofiber “highways” oriented radially from the tumor has
shown clinical correlation to increased metastases and
poor patient prognosis [25]. In the absence of biochemical
signaling, MDA-MB-231 cells are capable of migrating
200 μm, but this motion is not as efficient as migration in
the presence of a CXCL12 chemotactic gradient. MCF-
10A cells only traveled more than 100 μm when CXCL12
was presented as a gradient while the control and vehicle
conditions averaged only 85 μm of net migration. MCF-
10A cells on average migrated 105 μm on aligned nanofi-
ber, suggesting that these cells are capable of migrating
with high efficiency but display no sensitivity to CXCL12
gradients.
Gradient sensitivity
CXCR4 is the primary receptor for the potent chemotac-
tic chemokine CXCL12 [61]. Many in vivo studies exam-
ining invasion, intravasation, and distant colonization in
mouse models have shown that CXCR4 over-expressing
breast cancer cells are greatly sensitive to high levels of
CXCL12, creating the potential for enhanced, directed
cellular migration in the direction of the gradient[62,63]. In addition, paracrine signal loops between TAMS
and tumor-aiding fibroblasts that secrete CXCL12 to
CXCR4 over-expressing breast cancer cells increase the ef-
fectiveness of epidermal growth factor (EGF) gradients
significantly increasing the occurrence of metastasis [64].
Conversely, compounds that block expression of CXCR4
result in a decreased anti-metastatic effect to the inhib-
ition of leukocyte chemotaxis that relies on CXCR4/
CXCL12 signaling [64,65]. RT-PCR analysis of MCF-10A,
MCF-7, and MDA-MB-231 cells showed that each of the
cell lines initially express CXCR4 (Figure 9 (LEFT)), but
have significantly different levels of expression and thus
differences in sensitivity to the ligand CXCL12. This find-
ing suggests that MCF-10A and MCF-7 cells are less
sensitive to low levels of CXCL12 compared to MDA-MB-
231 cells, likely causing a different phenotypic response to
gradients of CXCL12. MCF-10A cells display less sensitiv-
ity to CXCL12 gradients resulting in no significant differ-
ences in net distance traveled compared to control or
vehicle experimental conditions. MCF-7 cells display more
sensitivity to CXCL12, showing that when CXCL12 is
present in low concentrations the expression of CXCR4 is
down regulated to modulate the response. As a result,
MCF-7 cells displayed statistically significant increases in
total and net distance traveled when CXCL12 was present
compared to cells not exposed to the chemokine. The
trend continues with increasing metastatic potential in the
cell lines, showing that MDA-MB-231 cells are very sensi-
tive to small concentrations of CXCL12 and modulate ex-
pression of CXCR4 once the gradient has dissipated in
order to find the ligand. The sensitivity that MDA-MB-
231 cells displayed in response to CXCL12 gradients re-
sulted in significant increases in net distance traveled.
Large standard deviations suggest that many of the cells
were capable of migrating distances larger than 300 μm.
However, as a result of CXCL12 sensitivity and gradient
dissipation versus time, MDA-MB-231 cells displayed a
deceleration with time causing significant reductions in
displacement of the cells at later time points (16–24 h) as
a result of the depletion of the CXCL12 gradient after
8 hours. MCF-10A cells and MCF-7 cells displayed con-
stant or slightly positive acceleration values over the 24-
hour period due to their inherently lower sensitivity to
CXCL12.
The migration results from MDA-MB-231 tumor cells
leaving a tumor biopsy depict trends similar to the cell
lines inoculated as individual cell populations. Inte-
restingly, significant increases in total and net distance
traveled were observed. Further testing and experiments
will be conducted using the nanofiber platform in-
tegrated with diffusive chemotactic gradients. Current
results suggest that this platform can be an effective
means of evaluating patient tumor biopsies for ma-
lignant cell populations and migration potential while
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compounds.
Conclusions
While it is well understood that early detection is the
best prevention of metastasis in breast cancer, tumor
cells located in the margins following surgical lumpec-
tomy or mastectomy contain populations of dormant
cancer stem cells that can result in distant metastases
and reduce patient survival [66-69]. Nearly 50% of pa-
tients undergoing breast tumor surgical conservation or
full mastectomy therapy require a secondary excision
due to positive margins [68]. Triple-negative breast can-
cer patients are most susceptible to recurrence and dis-
tant metastases within the first 3 years after surgical
therapy even after follow-up chemotherapy or radiation
[66,67]. If novel anti-metastatic drugs are to be devel-
oped at a faster rate to prevent recurrence and relapse,
in vitro platforms that better recapitulate the micro-
environment of in vivo tissues must be developed. The
use of electrospun nanofiber has been recently utilized
for tissue engineering applications. This report has dem-
onstrated efficacy in the use of nanofiber-based plat-
forms to evaluate the migration and metastatic potential
of breast cancer cells. The unique electrospun nanofiber
microstructure and morphology mimics native ECM,
and alignment can be controlled to provide either aligned
or random nanofiber orientations. A combination of ma-
trix alignment and increased migration potential of breast
cancer cells allows for increased total and net migration
distances not present in other assays (Table 4). Nearly
2-fold increases in net migration distance for MDA-
MB-231 cells in the presence of a CXCL12 gradient
suggest that drug evaluation should be conducted under
conditions that optimize cell migration. This study suggests
that use of a synthetic form of a nanoscale model could
provide a convenient means of testing the efficacy of novel
experimental anti-metastatic compounds.
Additional files
Additional file 1: Plot displays the release profiles of FITC labeled
BSA protein from an agarose gel over a 24-hr time period.
Additional file 2: MDA-MB-231 time-lapse video footage of cell
migration on random nanofiber substrates, displaying cells reaching
out filopodia attaching and anchoring to multiple fibers in multiple
directions essentially preventing substantial net migration.
Additional file 3: MDA-MB-231 time-lapse video footage of cell
migration on aligned nanofiber substrates, displaying highly-
elongated cells with filopodia stretched out in the direction of fiber
alignment allowing for and aiding migration.
Additional file 4: MDA-MB-231 time-lapse video footage of cell
migration on aligned nanofiber substrates in the presence of an
applied CXCL12 chemokine gradient, providing enhanced and more
directed migration along fibers into an increasing chemokine
concentration.Additional file 5: Explanted GFP-labeled MDA-MB-231 breast tumor
needle-biopsy from a SCID mouse displaying attachment of tumor
cells (green) and ensuing migration in the direction of nanofiber
alignment. Significant dispersion of tumor cells from the biopsy in the
direction of fiber alignment occurred over the 24-hr period.
Additional file 6: Confocal microscopy images displaying the shape
and morphology of MCF10A cells on plastic.
Additional file 7: Confocal microscopy images displaying the shape
and morphology of MCF10A cells on random nanofiber.
Additional file 8: Confocal microscopy images displaying the shape
and morphology of MCF10A cells on aligned nanofiber.
Additional file 9: Confocal microscopy images displaying the shape
and morphology of MCF7 cells on plastic.
Additional file 10: Confocal microscopy images displaying the
shape and morphology of MCF7 cells on random nanofiber.
Additional file 11: Confocal microscopy images displaying the
shape and morphology of MCF7 cells on aligned nanofiber.
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